Literature DB >> 19079809

Neurocognitive impairment in unaffected siblings of youth with bipolar disorder.

A E Doyle1, J Wozniak, T E Wilens, A Henin, L J Seidman, C Petty, R Fried, L M Gross, S V Faraone, J Biederman.   

Abstract

BACKGROUND: There is growing evidence for the familiality of pediatric bipolar disorder (BPD) and its association with impairments on measures of processing speed, verbal learning and 'executive' functions. The current study investigated whether these neurocognitive impairments index the familial risk underlying the diagnosis.
METHOD: Subjects were 170 youth with BPD (mean age 12.3 years), their 118 non-mood-disordered siblings and 79 non-mood-disordered controls. Groups were compared on a battery of neuropsychological tests from the Wechsler Intelligence Scales, the Stroop Color Word Test, the Wisconsin Card Sorting Test (WCST), the Rey-Osterrieth Complex Figure (ROCF), an auditory working memory Continuous Performance Test (CPT) and the California Verbal Learning Test-Children's Version (CVLT-C). Measures were factor analyzed for data reduction purposes. All analyses controlled for age, sex and attention-deficit/hyperactivity disorder (ADHD).
RESULTS: Principal components analyses with a promax rotation yielded three factors reflecting: (1) processing speed/verbal learning, (2) working memory/interference control and (3) abstract problem solving. The CPT working memory measure with interference filtering demands (WM INT) was only administered to subjects aged > or =12 years and was therefore analyzed separately. BPD youth showed impairments versus controls and unaffected relatives on all three factors and on the WM INT. Unaffected relatives exhibited impairments versus controls on the abstract problem-solving factor and the WM INT. They also showed a statistical trend (p=0.07) towards worse performance on the working memory/interference control factor.
CONCLUSIONS: Neurocognitive impairments in executive functions may reflect the familial neurobiological risk mechanisms underlying pediatric BPD and may have utility as endophenotypes in molecular genetic studies of the condition.

Entities:  

Mesh:

Year:  2008        PMID: 19079809      PMCID: PMC2853769          DOI: 10.1017/S0033291708004832

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  54 in total

1.  Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging.

Authors:  O Monchi; M Petrides; V Petre; K Worsley; A Dagher
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

2.  Furthering the scientific foundation of pediatric bipolar disorder.

Authors:  Joseph Biederman; Regina Smith James
Journal:  J Affect Disord       Date:  2004-10       Impact factor: 4.839

3.  A longitudinal twin study on IQ, executive functioning, and attention problems during childhood and early adolescence.

Authors:  Tinca J C Polderman; M Florencia Gosso; Danielle Posthuma; Toos C E M Van Beijsterveldt; Peter Heutink; Frank C Verhulst; Dorret I Boomsma
Journal:  Acta Neurol Belg       Date:  2006-12       Impact factor: 2.396

4.  Attention deficit, conduct, oppositional, and anxiety disorders in children: I. A review of research on differentiating characteristics.

Authors:  J S Werry; J C Reeves; G S Elkind
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-03       Impact factor: 8.829

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach.

Authors:  S Kéri; O Kelemen; G Benedek; Z Janka
Journal:  Psychol Med       Date:  2001-07       Impact factor: 7.723

Review 7.  The genetics of pediatric-onset bipolar disorder.

Authors:  Stephen V Faraone; Stephen J Glatt; Ming T Tsuang
Journal:  Biol Psychiatry       Date:  2003-06-01       Impact factor: 13.382

8.  Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania.

Authors:  Rebecca Elliott; Alan Ogilvie; Judy S Rubinsztein; Gloria Calderon; Raymond J Dolan; Barbara J Sahakian
Journal:  Biol Psychiatry       Date:  2004-06-15       Impact factor: 13.382

9.  Examination of concordance between maternal and youth reports in the diagnosis of pediatric bipolar disorder.

Authors:  Joseph Biederman; Carter R Petty; Timothy E Wilens; Thomas Spencer; Aude Henin; Stephen V Faraone; Eric Mick; Michael C Monuteaux; Deborah Kenealy; Tara Mirto; Janet Wozniak
Journal:  Bipolar Disord       Date:  2009-05       Impact factor: 6.744

10.  Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls.

Authors:  S Sobczak; A Honig; J A J Schmitt; W J Riedel
Journal:  Neuropsychopharmacology       Date:  2002-09-06       Impact factor: 7.853

View more
  19 in total

1.  Cross-Disorder Cognitive Impairments in Youth Referred for Neuropsychiatric Evaluation.

Authors:  Alysa E Doyle; Pieter J Vuijk; Nathan D Doty; Lauren M McGrath; Brian L Willoughby; Ellen H O'Donnell; H Kent Wilson; Mary K Colvin; Deanna C Toner; Kelsey E Hudson; Jessica E Blais; Hillary L Ditmars; Stephen V Faraone; Larry J Seidman; Ellen B Braaten
Journal:  J Int Neuropsychol Soc       Date:  2017-08-04       Impact factor: 2.892

2.  Neural correlates of cognitive flexibility in children at risk for bipolar disorder.

Authors:  Pilyoung Kim; Sarah E Jenkins; Megan E Connolly; Christen M Deveney; Stephen J Fromm; Melissa A Brotman; Eric E Nelson; Daniel S Pine; Ellen Leibenluft
Journal:  J Psychiatr Res       Date:  2011-10-22       Impact factor: 4.791

3.  A functional MRI study of working memory in adolescents and young adults at genetic risk for bipolar disorder: preliminary findings.

Authors:  Heidi W Thermenos; Nikos Makris; Susan Whitfield-Gabrieli; Ariel B Brown; Anthony J Giuliano; Erica H Lee; Stephen V Faraone; Ming T Tsuang; Larry J Seidman
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744

4.  Memory in early onset bipolar disorder and attention-deficit/hyperactivity disorder: similarities and differences.

Authors:  Anne H Udal; Bjørg Oygarden; Jens Egeland; Ulrik F Malt; Berit Groholt
Journal:  J Abnorm Child Psychol       Date:  2012-10

Review 5.  Neurocognitive performance in children and adolescents with bipolar disorder: a review.

Authors:  Karin Horn; Veit Roessner; Martin Holtmann
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-09-09       Impact factor: 4.785

6.  Cognitive dysfunction is worse among pediatric patients with bipolar disorder Type I than Type II.

Authors:  Lindsay S Schenkel; Amy E West; Rachel Jacobs; John A Sweeney; Mani N Pavuluri
Journal:  J Child Psychol Psychiatry       Date:  2012-02-17       Impact factor: 8.982

7.  Striatal dysfunction during failed motor inhibition in children at risk for bipolar disorder.

Authors:  Christen M Deveney; Megan E Connolly; Sarah E Jenkins; Pilyoung Kim; Stephen J Fromm; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-03-04       Impact factor: 5.067

8.  Early-onset bipolar disorder: how about visual-spatial skills and executive functions?

Authors:  Sara Lera-Miguel; Susana Andrés-Perpiñá; Rosa Calvo; Mar Fatjó-Vilas; Lourdes Fañanás; Fañanás Lourdes; Luisa Lázaro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-11-18       Impact factor: 5.270

Review 9.  Neurocognitive functioning in euthymic patients with bipolar disorder and unaffected relatives: A review of the literature.

Authors:  Stephanie A Cardenas; Layla Kassem; Melissa A Brotman; Ellen Leibenluft; Francis J McMahon
Journal:  Neurosci Biobehav Rev       Date:  2016-08-05       Impact factor: 8.989

10.  Norepinephrine and impulsivity: effects of acute yohimbine.

Authors:  Alan C Swann; Marijn Lijffijt; Scott D Lane; Blake Cox; Joel L Steinberg; F Gerard Moeller
Journal:  Psychopharmacology (Berl)       Date:  2013-04-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.